Akili
Akili developed EndeavorRx, the first video game cleared by the FDA as a prescription treatment, indicated for attention in children with ADHD. After going public via a SPAC in 2022 the company struggled commercially, and it was acquired by Virtual Therapeutics in 2024 in a deal valuing it at about $34 million.
- Founded
- 2011
- Headquarters
- Boston, Massachusetts, US
- Founders
- Eddie Martucci, Adam Gazzaley
- Status
- Acquired (by Virtual Therapeutics, 2024)
- Valuation
- ~$34M acquisition (2024)
- Category
- Digital therapeutics
- Products
- EndeavorRx, EndeavorOTC
Covered in: Digital Therapeutics
Sources
Profile compiled from the public sources listed above. Funding, valuation, and employee figures are point-in-time and may be out of date.